In a landmark decision that redefines the boundaries of pharmaceutical innovation, the U.S. Food and Drug Administration has officially approved a groundbreaking gene therapy developed not by a corporate giant, but by an Italian non-profit foundation, offering a potential cure for a devastating
Introduction Seizing the Opportunity for Real Reform With the scheduled expiration of enhanced Obamacare subsidies creating an urgent policy crossroads, the nation has a rare chance to pivot away from temporary government fixes toward a more sustainable and market-driven healthcare system. The
In a world where consumer technology has mastered the art of holding our attention, the healthcare industry often struggles to get patients to even show up for an appointment. Faisal Zain, a veteran expert in medical technology and innovation, argues this isn't a failure of patient motivation,
As the clock ticks down on the enhanced federal health insurance subsidies set to expire at the end of the year, millions of Americans are bracing for a potential financial shock while policymakers debate whether this looming deadline is a crisis or a catalyst. This policy crossroads has reignited
In a nation where health care costs continue to climb at an alarming rate, a contentious debate has erupted over the role of Health Savings Accounts (HSAs) as a potential lifeline for millions of Americans struggling with Affordable Care Act (ACA) marketplace plans. With enhanced subsidies for ACA
A Critical Moment for Drug Pricing Reform Imagine a healthcare system where the cost of life-saving medications is dictated not by production expenses or patient needs, but by hidden negotiations between powerful middlemen. This is the reality for millions of Americans grappling with soaring
